You indicated that you are taking medication(s) for your (identify health concern, such as “high blood pressure”). Individuals have identified several issues regarding their medication-taking behavior, and we are interested in your experiences. There is no right or wrong answer. Please answer each question based on your personal experience with your [health concern] medication.
1. Do you sometimes forget to take your medication?
2. People sometimes forget to take their medications for reasons other than forgetting. Thinking over the past two weeks, were there any days when you did not take your medication?
3. Have you ever cut back or stopped taking your medication without telling your doctor, because you felt worse when you took it?
4. When you travel or leave home, do you sometimes forget to bring your medication?
5. Did you take your medication the last time you were supposed to take it?
6. When you feel like your symptoms are under control, do you sometimes stop taking your medication?
7. Taking medication every day is a real inconvenience for some people. Do you ever feel hassled about sticking to your treatment plan?
8. How often do you have difficulty remembering to take all your medications?
Customizable packages for healthcare organizations
End-User License Agreement (EULA) for Authorization to Use the MMAS in Research and Publication
1. Introduction
This End-User License Agreement (EULA) is a legal agreement between the user ("Licensee") and MMAR, LLC dba ADHERENCE ("Licensor") of the Morisky Medication Adherence Scale (MMAS). By using the MMAS for research and publication, the Licensee agrees to be bound by the terms and conditions of this EULA.
2. Grant of License
The Licensor grants the Licensee a non-exclusive, non-transferable, limited license to use the MMAS for the purposes of research and publication as specified herein. This license is granted on the condition that the Licensee adheres to all terms and conditions set forth in this EULA.
3. Use Restrictions
The Licensee agrees to use the MMAS solely for academic, clinical, or research purposes. The Licensee shall not:
- Distribute, sublicense, lease, sell, or otherwise transfer the MMAS to any third party.
- Reverse engineer, decompile, or disassemble the MMAS.
- Publish, disclose, or share the MMAS scoring algorithm, which remains a protected trade secret of the Licensor.
4. Confidentiality
The Licensee acknowledges that the MMAS scoring algorithm is confidential and proprietary information. The Licensee agrees to:
- Maintain the confidentiality of the scoring algorithm.
- Take all reasonable measures to protect the confidentiality of the scoring algorithm.
- Not disclose the scoring algorithm to any third party without the prior written consent of the Licensor.
5. Data Reporting and Publication
The Licensee may use the MMAS in research and publications under the following conditions:
- Proper attribution must be given to the Licensor in any research reports, articles, or publications that include data derived from the MMAS.
©MMAS 2006 used with permission www.adherence.cc
- The Licensee provide the Licensor with a copy of any published research that includes data derived from the MMAS.
- The Licensee may not disclose the detailed scoring algorithm in any publication or presentation.
- The scoring must be posted as follows:
The MMAS-8 scale consists of 8 items. Each of the first 7 items has 2 possible responses (yes/no), while the 8th item is answered with a 5-point Likert scale. The possible total medication adherence score ranges between 0 and 8, and the higher the score, the better the adherence level. A total score < 6 is considered low adherence, while a total score of ≥ 6 but < 8 indicates moderate adherence, and a score of 8 indicates high adherence.
6. Ownership
The MMAS and all associated intellectual property rights remain the sole property of the Licensor. This EULA does not grant the Licensee any ownership rights in the MMAS or its scoring algorithm.
7. Termination
This license is effective until terminated. The Licensor may terminate this license at any time if the Licensee breaches any of the terms and conditions of this EULA. Upon termination, the Licensee must cease all use of the MMAS and destroy all copies of the MMAS in their possession.
8. Limitation of Liability
The MMAS is provided "as is" without any warranties, express or implied. The Licensor shall not be liable for any damages arising out of or in connection with the use or performance of the MMAS.
9. Governing Law
This EULA shall be governed by and construed in accordance with the laws of the state of California, without regard to its conflict of laws principles.
10. Entire Agreement
This EULA constitutes the entire agreement between the Licensee and the Licensor with respect to the use of the MMAS and supersedes all prior or contemporaneous understandings regarding such subject matter.
11. Amendments
The Licensor reserves the right to amend the terms of this EULA at any time. Any amendments will be effective upon notice to the Licensee.
By using the MMAS, you acknowledge that you have read, understood, and agree to be bound by the terms and conditions of this EULA.
Copyright © 2023 adherence. - All Rights Reserved. Patient adherence Medication Adherence MMAS MMAS-4 MMAS-8 Morisky Medication Adherence Scale Morisky Scale
health tech, digital health, telehealth, healthcare innovation, medical technology, ehealth, health informatics, remote patient monitoring, mhealth, telemedicine, patient engagement, wearable health devices, health app, ai in healthcare, telehealth solutions, virtual care, health tech startups, connected health, population health management, healthcare analytics, personalized medicine
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.